Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Wyeth withdraws marketing authorization application of vasomotor drug
In its official letter, the company stated that the withdrawal of Pristiqs was based on its plans to conduct additional clinical studies that would address the Committee for
In its official letter, the company stated that the withdrawal of Pristiqs was based on its plans to conduct additional clinical studies that would address the Committee for
Erwinase and Kidrolase are oncology drugs used in the treatment of acute lymphoblastic leukemia. Janet Greeson, CEO of Samaritan, said: “We are always enthusiastic about growing our marketing
Under this agreement, Mercury Therapeutics (MTI) has licensed to Makoto its lead series of high potency activators of AMP-activated protein kinase (AMPK), a well validated drug target for
Mr Holveck was most recently president of Johnson & Johnson Development Corporation and vice president, corporate development of Johnson & Johnson. He received a BS in education and
The techniques and patents provide significant protection for InNexus’s latest scientific achievement and growing product pipeline. Thomas Kindt, chief scientific officer of InNexus, said: “The DXLmouse is another
The Episcan will be used as part of the facilities’s admission process and for regular ongoing skin assessment protocols. Installation of the units is expected to commence in
The two studies, Zodiac (Zactima in combination with docetaxel in non-small cell lung cancer) and Zeal (Zactima efficacy with alimta in lung cancer), are the second and third
The definitive acquisition agreement contemplates that China Aoxing will acquire 100% ownership of Shijiazhuang Lerentang. The purchase price will be paid approximately $10.8 million in cash and eight
This agreement resulted from the strategic alliance entered into by Tacere and Oncolys in June 2007, whereby Oncolys was granted an option to acquire the Asian rights for
The partnership will focus on the distribution of medical surgical products and services in 10 states. This three-year agreement creates a partnership of shared responsibility to ensure Amerinet